ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02970318
Brief Title: A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL

First Submitted : November 18, 2016
First Submitted that Met QC Criteria : November 18, 2016
First Posted : November 22, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 23, 2017
Last Update Posted : May 25, 2017